Akorn Pharma recalls Acetaminophen 500 mg tablets with missing imprints
Akorn Pharma, Inc. is recalling Acetaminophen 500 mg Extra Strength tablets because the imprint identification marking is missing from the tablets. The recall affects 30,325 bottles distributed to wholesalers.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recall for a labeling specification defect. The missing imprint constitutes a minor labeling error. The rubric specifies that FDA Class III recalls are typically scored 1 or 2. This qualifies as Score 2 - Moderate due to the labeling/identification nature of the defect.
Plain-English summary
Akorn Pharma, Inc. is recalling Acetaminophen 500 mg Extra Strength tablets due to failed tablet specifications. The imprint 'AP 325' is missing from the affected tablets.
The affected product was distributed to six distributors and wholesalers. Approximately 30,325 bottles are subject to this recall, available in two package sizes: 100-count bottles (NDC 71399-8022-01) and 1000-count bottles (NDC 71399-8022-02).
The recall affects multiple lot numbers with expiration dates ranging from November 2022 through February 2023. Consumers who may have purchased the recalled product should contact their pharmacist or healthcare provider with questions about identification or replacement.
The recalled product
- Product
- Acetaminophen 500 mg tablet, Extra Strength, packaged in a) 100-count bottle (NDC 71399-8022-01), b) 1000-count bottle (NDC 71399-8022-02), Akorn Pharma Manufactured for: Akorn Pharma, Inc., Fairfield, NJ
- Manufacturer
- Akron Pharma, Inc.
- Hazard
- missing-imprint
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot#: AXA2014
- Exp Feb-23
- AXB2001
- Exp Nov-22
- AXB2002
- AXB2003
- AXB2004
- AXB2005
- AXB2006
- AXB2007
- AXB2008
- AXB2009
- AXB2010
- AXB2011
- Exp Dec-22
- AXB2012
- AXB2013
- AXB2014
- AXB2015
- AXB2016
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27